Calculator Template: Difference between revisions
Gerald Chi (talk | contribs) |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 9: | Line 9: | ||
==[Name of the Score]== | ==[Name of the Score]== | ||
[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references) | [Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references) | ||
[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition). | [Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition). | ||
| Line 21: | Line 18: | ||
[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population). | [Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population). | ||
==[Name of the Score] Calculator== | ==[Name of the Score] Calculator== | ||
| Line 34: | Line 28: | ||
* Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization. | * Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization. | ||
* Score ≥4: high-risk (>5% mortality); treatment/hospitalization is warranted. | * Score ≥4: high-risk (>5% mortality); treatment/hospitalization is warranted. | ||
==Guideline Recommendations== | |||
[Name of the Score] has been included in the (ACC/AHA/ESC/ACCP) guideline recommendations for the (risk assessment/diagnosis/exclusion) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population) (class of recommendation: XXX; level of evidence: XXX). | |||
==See also== | ==See also== | ||
Revision as of 23:18, 29 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)
Synonyms and keywords: (add synonyms and create redirects)
Overview
[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/10-year/other timeframe) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
[Name of the Score]
[Name of the Score] was invented by (Author) et al in (year), and has been externally validated in (other populations/subsequent studies).(add references)
[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other end point) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other condition).
[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.
[Name of the Score] is a (prediction model) developed to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).
[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).
[Name of the Score] Calculator
Shown below is the calculator for [Name of the Score] (check all the boxes that apply):
(insert widget here)
Interpretation
- Score ≤1: low-risk (<1% mortality); no treatment or hospital admission is required.
- Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
- Score ≥4: high-risk (>5% mortality); treatment/hospitalization is warranted.
Guideline Recommendations
[Name of the Score] has been included in the (ACC/AHA/ESC/ACCP) guideline recommendations for the (risk assessment/diagnosis/exclusion) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population) (class of recommendation: XXX; level of evidence: XXX).
See also
- (Relevant score 1)
- (Relevant score 2)
- (Relevant score 3)